tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DSGN Stock Latest News

Design Therapeutics Advances GeneTAC Programs Amid FDA Hold
Company AnnouncementsDesign Therapeutics Advances GeneTAC Programs Amid FDA Hold
4d ago
8K
DSGN
Design Therapeutics reports Q2 EPS (34c), consensus (33c)
PremiumThe Fly
Design Therapeutics reports Q2 EPS (34c), consensus (33c)
4d ago
DSGN
Design Therapeutics Faces Financial Strain Amid International Trade Challenges
PremiumCompany Announcements
Design Therapeutics Faces Financial Strain Amid International Trade Challenges
18d ago
DSGN
Design Therapeutics Confirms Directors at Annual Meeting
PremiumCompany Announcements
Design Therapeutics Confirms Directors at Annual Meeting
2M ago
8K
DSGN
Design Therapeutics announces first FA patient dosed in RESTORE-FA trial
PremiumThe Fly
Design Therapeutics announces first FA patient dosed in RESTORE-FA trial
2M ago
DSGN
Design Therapeutics files $300M mixeds securities shelf
PremiumThe FlyDesign Therapeutics files $300M mixeds securities shelf
3M ago
DSGN
Controversial doctor Vinay Prasad named CBER director, STAT reports
Premium
The Fly
Controversial doctor Vinay Prasad named CBER director, STAT reports
3M ago
DYN
RNA
Cautious Optimism for Design Therapeutics: Hold Rating Amid Promising Phase 1 Results and Extended Development Timeline
Premium
Ratings
Cautious Optimism for Design Therapeutics: Hold Rating Amid Promising Phase 1 Results and Extended Development Timeline
3M ago
DSGN
Design Therapeutics announces data from Phase 1 SAD/MAD trial of DT-168
PremiumThe Fly
Design Therapeutics announces data from Phase 1 SAD/MAD trial of DT-168
3M ago
DSGN
RBC sees Makary interview as potentially positive for biotech stocks
PremiumThe Fly
RBC sees Makary interview as potentially positive for biotech stocks
4M ago
DYN
RNA
Design Therapeutics appoints Chris Storgard as CMO
PremiumThe Fly
Design Therapeutics appoints Chris Storgard as CMO
4M ago
DSGN
Design Therapeutics price target raised to $5 from $4 at RBC Capital
PremiumThe Fly
Design Therapeutics price target raised to $5 from $4 at RBC Capital
5M ago
DSGN
Design Therapeutics reports Q4 EPS (24c), consensus (27c)
PremiumThe FlyDesign Therapeutics reports Q4 EPS (24c), consensus (27c)
5M ago
DSGN
Design Therapeutics provides corporate highlights, anticipated milestones
Premium
The Fly
Design Therapeutics provides corporate highlights, anticipated milestones
5M ago
DSGN
Design Therapeutics sees cash runway into 2029
Premium
The Fly
Design Therapeutics sees cash runway into 2029
5M ago
DSGN
DSGN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
DSGN Earnings this Week: How Will it Perform?
5M ago
DSGN
Design Therapeutics Updates Corporate Presentation for Investors
PremiumCompany Announcements
Design Therapeutics Updates Corporate Presentation for Investors
7M ago
8K
DSGN
Design Therapeutics Reports Strong Q3 and Pipeline Progress
PremiumCompany Announcements
Design Therapeutics Reports Strong Q3 and Pipeline Progress
9M ago
DSGN
Design Therapeutics reports Q3 EPS (23c), consensus (24c)
PremiumThe Fly
Design Therapeutics reports Q3 EPS (23c), consensus (24c)
9M ago
DSGN
Is DSGN a Buy, Before Earnings?
PremiumPre-EarningsIs DSGN a Buy, Before Earnings?
9M ago
DSGN
Design Therapeutics expects cash to fund expenses into 2029
Premium
The Fly
Design Therapeutics expects cash to fund expenses into 2029
1y ago
DSGN
Design Therapeutics reports Q2 EPS (21c), consensus (23c)
Premium
The Fly
Design Therapeutics reports Q2 EPS (21c), consensus (23c)
1y ago
DSGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >